AA
CTEV

Antipodean Advisors’s Claritev Corp CTEV Stock Holding History

Antipodean Advisors’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,600
Closed -$1.91M – 12
2021
Q1 		$1.91M Buy
+8,600
New +$2.48M 0.59% 9

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SMR
SIH MPH Rollover New York $232M AUM 45.07% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return

Antipodean Advisors's CTEV Position: Q2 2021 in Review

Antipodean Advisors sold out of Claritev Corp (CTEV) in Q2 2021, closing a stake of 8,600 shares — an estimated $1.91M sold.

Antipodean Advisors first reported a position in CTEV in Q1 2021 and held it in 1 quarter. The position peaked at $1.91M in Q1 2021. 108 funds tracked by Wall St. Rank hold CTEV as of Q2 2021.

  • Antipodean Advisors reported no remaining Claritev Corp position as of Q2 2021 after selling out during the quarter.
  • Antipodean Advisors sold 8,600 Claritev Corp shares in Q2 2021, an estimated $1.91M.
  • Antipodean Advisors first reported a position in Claritev Corp in Q1 2021 and held it in 1 quarter.
  • Antipodean Advisors's Claritev Corp position peaked at $1.91M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Claritev Corp as of Q2 2021.

Based on Antipodean Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.